EMPLOYMENT AGREEMENTEmployment Agreement • July 29th, 2021 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 29th, 2021 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of 17 May, 2021, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Andrew Saik (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • July 29th, 2021 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 29th, 2021 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of 2 June, 2021, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and M. Michelle Berrey (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2021 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 6th, 2021 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of February 9th, 2021, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Lisa DeFrancesco (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2021 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 6th, 2021 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of January 4th, 2021, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Bryan Ball (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 6th, 2021 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 6th, 2021 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of February 15th, 2021, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Linda Richardson (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 25th, 2021 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2021 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of December 18th, 2020, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Jared Freedberg (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of November 27, 2017, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and David Shapiro (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of April 14, 2017, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and David Ford (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of November 2, 2017, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Christian Weyer (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 25th, 2020 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 25th, 2020 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”), made effective as of November 19, 2019, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Jason Campagna (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2019 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2019 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of January 22nd, 2018 is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Ryan Sullivan (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2019 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2019 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of February 6th, 2018, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Gail Cawkwell (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 1st, 2017 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledDecember 1st, 2017 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of November 27, 2017, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and David Shapiro (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 1st, 2017 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledDecember 1st, 2017 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of November 2, 2017, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Christian Weyer (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 3rd, 2017 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 3rd, 2017 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of April 14, 2017, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and David Ford (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 10th, 2017 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2017 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of February 15, 2017, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Jerome Durso (“Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 9th, 2016 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 9th, 2016 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of May 3, 2016, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Sandip S. Kapadia (“Executive”).